Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Olsen

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2005
Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleedingKeith M Olsen
The Journal of Family Practice|June 9, 2005
Pharmacologic agents associated with QT interval prolongationKeith M Olsen
Critical Care Medicine|April 10, 2002
Medication errors: problems identified, but what is the solution?Keith M Olsen
Pharmacotherapy|December 21, 2002
Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsisKeith M Olsen, Steven J Martin
Pharmacological Research|May 6, 2014
Statins role in the prevention and treatment of sepsisPaul P Dobesh, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Treatment algorithms in critical care: do they improve outcomes?Stephen W Nissen, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Introduction: infectious diseases in the critically illKeith M Olsen, Tien M H Ng
Expert Review of Pharmacoeconomics & Outcomes Research|July 26, 2014
Correlates and economic outcomes of proton pump inhibitor use by routes in intensive care unit patientsJayashri Sankaranarayanan, Tom Reardon, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patientsTammy M Winterboer, Kassandra A Lecci, Keith M Olsen
The Annals of Pharmacotherapy|October 6, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economicsJohn W Devlin, Lynda S Welage, Keith M Olsen
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2005
Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleedingKeith M Olsen
The Journal of Family Practice|June 9, 2005
Pharmacologic agents associated with QT interval prolongationKeith M Olsen
Critical Care Medicine|April 10, 2002
Medication errors: problems identified, but what is the solution?Keith M Olsen
Pharmacotherapy|December 21, 2002
Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsisKeith M Olsen, Steven J Martin
Pharmacological Research|May 6, 2014
Statins role in the prevention and treatment of sepsisPaul P Dobesh, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Treatment algorithms in critical care: do they improve outcomes?Stephen W Nissen, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Introduction: infectious diseases in the critically illKeith M Olsen, Tien M H Ng
Expert Review of Pharmacoeconomics & Outcomes Research|July 26, 2014
Correlates and economic outcomes of proton pump inhibitor use by routes in intensive care unit patientsJayashri Sankaranarayanan, Tom Reardon, Keith M Olsen
Journal of Pharmacy Practice|April 22, 2011
Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patientsTammy M Winterboer, Kassandra A Lecci, Keith M Olsen
The Annals of Pharmacotherapy|October 6, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economicsJohn W Devlin, Lynda S Welage, Keith M Olsen
Pageof 7